Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,262,293
-
Share change
-
-2,531,125
-
Total reported value
-
$81,752,172
-
Price per share
-
$3.37
-
Number of holders
-
80
-
Value change
-
-$11,517,176
-
Number of buys
-
45
-
Number of sells
-
35
Institutional Holders of JOUNCE THERAPEUTICS INC - COM (JNCE) as of Q4 2018
As of 31 Dec 2018,
JOUNCE THERAPEUTICS INC - COM (JNCE) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,262,293 shares.
The largest 10 holders included
TRV GP II, LLC, TRV GP III, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., FMR LLC, JPMORGAN CHASE & CO, Omega Fund Management, LLC, Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, and TWO SIGMA INVESTMENTS, LP.
This page lists
80
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.